Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16450821 | 0.89 | EPHX1 (0.45) | ACHE | |
| SCHEMBL4665170 | 0.88 | ACHE (0.49) | ACHEALOX15 | |
| SCHEMBL10832505 | 0.87 | ACHE (0.53) | ACHEUSP2 | |
| SCHEMBL7745030 | 0.80 | PRKCA (0.54) | ACHE | |
| SCHEMBL9683934 | 0.79 | ACHE (0.59) | ACHEALOX15 | |
| SCHEMBL26570584 | 0.79 | PRKCA (0.37) | ACHEUSP2 | |
| SCHEMBL26570591 | 0.79 | PRKCA (0.37) | ACHEUSP2 | |
| SCHEMBL9863630 | 0.79 | ACHE (0.50) | ACHEUSP2 | |
| SCHEMBL26570603 | 0.78 | PRKCA (0.37) | ACHEUSP2 | |
| SCHEMBL9575816 | 0.78 | LPAR5 (0.49) | ACHEUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080167489-A1 | Process for producing carbamoyloxy (meth) acrylates and new carbamoyloxy (meth) acrylates | STONE VINCENT | 2008-07-10 | — | — | US | disclosed |
| US-7329773-B2 | Process for producing carbamoyloxy (meth) acrylates and new carbamoyloxy (meth)acrylates | SURFACE SPECIALTIES, S.A. (BE) | 2008-02-12 | — | — | US | disclosed |
| US-20060058549-A1 | Process for producing carbamoyloxy (meth) acrylates and new carbamoyloxy (meth)acrylates | SURFACE SPECIALTIES, S.A. (BE) | 2006-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167489-A1 | Process for producing carbamoyloxy (meth) acrylates and new carbamoyloxy (meth) acrylates | NAT10, CNOT9, MMAB | ACHE 1129/4885USP2 1993/4885ALOX15 4207/4885 |
| US-20060058549-A1 | Process for producing carbamoyloxy (meth) acrylates and new carbamoyloxy (meth)acrylates | NAT10, CNOT9, MMAB | ACHE 1129/4885USP2 1993/4885ALOX15 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.